The NMPA (National Medical Products Administration) is China’s medical device regulator. Approval pathways differ materially from FDA and CE — Class III innovative devices can access the expedited “green channel” review, while routine Class II devices follow standard timelines. This list shows products in this database with a confirmed NMPA approval value recorded. The approval value typically encodes the year-month of clearance; treat it as a pointer to the NMPA registration query system rather than a standalone authoritative record.
For a plain-language summary of how NMPA approval data is sourced and verified in this database, see data methodology.